Literature DB >> 24200262

Towards the WHO target of zero childhood tuberculosis deaths: an analysis of mortality in 13 locations in Africa and Asia.

G K Russell1, C S Merle, G S Cooke, E C Casas, M Silveira da Fonseca, P du Cros.   

Abstract

SETTING: Achieving the World Health Organization (WHO) target of zero paediatric tuberculosis (TB) deaths will require an understanding of the underlying risk factors for mortality.
OBJECTIVE: To identify risk factors for mortality and assess the impact of human immunodeficiency virus (HIV) testing during anti-tuberculosis treatment in children in 13 TB-HIV programmes run by Médecins Sans Frontières.
DESIGN: In a retrospective cohort study, we recorded mortality and analysed risk factors using descriptive statistics and logistic regression. Diagnosis was based on WHO algorithm and smear microscopy.
RESULTS: A total of 2451 children (mean age 5.2 years, SD 3.9) were treated for TB. Half (51.0%) lived in Asia, the remainder in sub-Saharan Africa; 56.0% had pulmonary TB; 6.4% were diagnosed using smear microscopy; 211 (8.6%) died. Of 1513 children tested for HIV, 935 (61.8%) were positive; 120 (12.8%) died compared with 30/578 (5.2%) HIV-negative children. Risk factors included being HIV-positive (OR 2.6, 95%CI 1.6-4.2), age <5 years (1.7, 95%CI 1.2-2.5) and having tuberculous meningitis (2.6, 95%CI 1.0-6.8). Risk was higher in African children of unknown HIV status than in those who were confirmed HIV-negative (1.9, 95%CI 1.1-3.3).
CONCLUSIONS: Strategies to eliminate childhood TB deaths should include addressing the high-risk groups identified in this study, enhanced TB prevention, universal HIV testing and the development of a rapid diagnostic test.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24200262     DOI: 10.5588/ijtld.13.0238

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  8 in total

1.  Alternative dosing guidelines to improve outcomes in childhood tuberculosis: a mathematical modelling study.

Authors:  Kendra K Radtke; Kelly E Dooley; Peter J Dodd; Anthony J Garcia-Prats; Lindsay McKenna; Anneke C Hesseling; Radojka M Savic
Journal:  Lancet Child Adolesc Health       Date:  2019-07-16

2.  Pharmacokinetics of First-Line Antituberculosis Drugs Using WHO Revised Dosage in Children With Tuberculosis With and Without HIV Coinfection.

Authors:  Awewura Kwara; Anthony Enimil; Fizza S Gillani; Hongmei Yang; Anima M Sarfo; Albert Dompreh; Antoinette Ortsin; Lawrence Osei-Tutu; Sandra Kwarteng Owusu; Lubbe Wiesner; Jennifer Norman; Jaclynn Kurpewski; Charles A Peloquin; Daniel Ansong; Sampson Antwi
Journal:  J Pediatric Infect Dis Soc       Date:  2015-05-26       Impact factor: 3.164

3.  The effect of tuberculosis treatment on virologic and immunologic response to combination antiretroviral therapy among South African children.

Authors:  Heidi M Soeters; Shobna Sawry; Harry Moultrie; Annelies Van Rie
Journal:  J Acquir Immune Defic Syndr       Date:  2014-10-01       Impact factor: 3.731

4.  Survival of HIV-1 vertically infected children.

Authors:  Mary-Ann Davies; Diana Gibb; Anna Turkova
Journal:  Curr Opin HIV AIDS       Date:  2016-09       Impact factor: 4.283

5.  Excellent Treatment Outcomes in Children Treated for Tuberculosis Under Routine Operational Conditions in Cape Town, South Africa.

Authors:  Muhammad Osman; Kevin Lee; Karen Du Preez; Rory Dunbar; Anneke C Hesseling; James A Seddon
Journal:  Clin Infect Dis       Date:  2017-10-16       Impact factor: 9.079

6.  BUTIMBA: Intensifying the Hunt for Child TB in Swaziland through Household Contact Tracing.

Authors:  Anna Maria Mandalakas; Katherine Ngo; Pilar Alonso Ustero; Rachel Golin; Florence Anabwani; Bulisile Mzileni; Welile Sikhondze; Robert Stevens
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

Review 7.  Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta-analysis.

Authors:  Alba Navarro-Flores; Jose Ernesto Fernandez-Chinguel; Niels Pacheco-Barrios; David R Soriano-Moreno; Kevin Pacheco-Barrios
Journal:  J Neurol       Date:  2022-03-15       Impact factor: 4.849

Review 8.  Towards early inclusion of children in tuberculosis drugs trials: a consensus statement.

Authors:  Sharon Nachman; Amina Ahmed; Farhana Amanullah; Mercedes C Becerra; Radu Botgros; Grania Brigden; Renee Browning; Elizabeth Gardiner; Richard Hafner; Anneke Hesseling; Cleotilde How; Patrick Jean-Philippe; Erica Lessem; Mamodikoe Makhene; Nontombi Mbelle; Ben Marais; Helen McIlleron; David F McNeeley; Carl Mendel; Stephen Murray; Eileen Navarro; E Gloria Anyalechi; Ariel R Porcalla; Clydette Powell; Mair Powell; Mona Rigaud; Vanessa Rouzier; Pearl Samson; H Simon Schaaf; Seema Shah; Jeff Starke; Soumya Swaminathan; Eric Wobudeya; Carol Worrell
Journal:  Lancet Infect Dis       Date:  2015-05-06       Impact factor: 25.071

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.